Yumeng Wu
Bengbu, 233004, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
YTHDF1-ALYREF axis enhances mrna stability and tumor immune evasion in paediatric B-cell acute lymphoblastic leukemia.
Journal: Functional & integrative genomics
Published: September 17, 2025
Super-enhancer-driven ELOVL5 promotes T-ALL progression through the MYC-SERBP1 pathway.
Journal: Genomics
Published: June 03, 2025
Molecular insights into chemotherapy resistance mediated by MLL-AF9 fusion gene in pediatric B-cell acute lymphoblastic leukemia.
Journal: The Journal of biological chemistry
Published: January 10, 2025
The super-enhancer regulatory gene SH2D1A promotes the progression of T cell acute lymphoblastic leukemia by activating CHI3L2.
Journal: Cellular signalling
Published: January 06, 2025
Mechanistic role of GNE-987 targeting BRD4-HCP5 axis in pediatric T-cell acute lymphoblastic leukemia.
Journal: Journal of cell communication and signaling
Published: December 16, 2024
USP20 as a super-enhancer-regulated gene drives T-ALL progression via HIF1A deubiquitination.
Journal: Acta pharmaceutica Sinica. B
Published: November 12, 2024
Core transcriptional regulatory circuitry molecule ZNF217 promotes AML cell proliferation by up-regulating MYB.
Journal: International journal of biological sciences
Published: September 03, 2024
IRF1 is a core transcriptional regulatory circuitry member promoting AML progression by regulating lipid metabolism.
Journal: Experimental hematology & oncology
Published: September 03, 2024
Enhancer looping protein LDB1 modulates MYB expression in T-ALL cell lines in vitro by cooperating with master transcription factors.
Journal: Journal of experimental & clinical cancer research : CR
Published: January 28, 2024
Super enhancer related gene ANP32B promotes the proliferation of acute myeloid leukemia by enhancing MYC through histone acetylation.
Journal: Cancer cell international
Published: October 27, 2023
The heterogeneity of signaling pathways and drug responses in intrahepatic cholangiocarcinoma with distinct genetic mutations.
Journal: Cell death & disease
Published: May 14, 2023
Last Updated: 09/26/2026